NCT06314425

Brief Summary

This study is a prospective case series clinical study to examine the effectiveness of Ceramic dental implants manufactured by Swiss Dental Solutions (SDS). Participants with an indication from the dentist for teeth extraction and replacement are invited to participate in this study. Participating in this study will involve the use of dental implants manufactured by Swiss Dental Solutions (SDS zirconia dental implants), submission of the case data, including pre-operative information, intra-operative details, and post-operative follow-up data, to the study site and its collaborating partners. The SDS zirconia dental implants used in this research are FDA cleared devices that are available for dental treatments.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Dec 2026

First Submitted

Initial submission to the registry

March 7, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

January 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2025

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

June 6, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

March 7, 2024

Last Update Submit

June 4, 2025

Conditions

Keywords

ceramic implantstitanium implantsperi-implantitismarginal bone losssoft tissuebone augmentationimmediate implantationdental implantsimmediate loading

Outcome Measures

Primary Outcomes (1)

  • Cumulative Survival Rate (CSR)

    The cumulative survival rate is determined as the percentage of implants that remained in place over the observation period for each patient. 100% of survival is defined as absence of implant loss.

    12-month follow-up

Secondary Outcomes (1)

  • Marginal Bone Loss (MBL)

    12-month follow-up

Other Outcomes (1)

  • Pink Esthetic Score (PES)

    12-month follow-up

Study Arms (1)

Immediate loading of ceramic implants

EXPERIMENTAL

Tooth/teeth are extracted with minimally invasive approach using piezo surgery and when necessary sectioning after local anesthesia (Articaine 40 mg/mL with epinephrine 10 μg/mL; or Lidocaine 20mg/ml with 10 ug/ml). Extraction sockets are thoroughly degranulated to remove all remnants of soft tissue and residual restorations or material which may have extended beyond the tooth apex. After copious irrigation, the socket condition is recorded, which includes, thickness and location of buccal/facial crestal alveolar bone.

Procedure: Immediate dental implants placements on fresh sockets after tooth extraction

Interventions

Zirconia dental implants (SDS®, Swiss Dental Solution, Kreuzlingen, Switzerland) are to be placed within the fresh extraction sockets. The immediate implants are placed using a minimally invasive technique without vertical releasing incisions. Implant placements are performed following the SDS osteotomy protocol after sulcus marginal and crestal incision or flapless surgery. The same surgeon places implants for all patients. Infected sites are debrided using piezo surgery touch.

Immediate loading of ceramic implants

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The need for implant placement in position of single or multiple teeth to be extracted and to replace up to 3 teeth
  • Availability of patient for a minimum follow-up of one year following implantation
  • Availability of complete follow-up data in medical records
  • Availability of post-operative and follow-up periapical radiographs

You may not qualify if:

  • History of head and neck irradiation
  • History of bisphosphonate or medications that induce osteonecrosis of the jaw
  • Untreated systemic diseases that are known to affect wound healing, such as uncontrolled diabetes mellitus
  • Immunocompromised or immunoproliferative diseases
  • Heavy Smoking of \>10 cigarettes per day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vizstara Professional Education

Englewood Cliffs, New Jersey, 07632, United States

Location

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Etyene Schnurr, DMD PhD DSc MSc

    Vizstara Professional Education, Clinical and R & D

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 18, 2024

Study Start

January 3, 2025

Primary Completion

April 24, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

June 6, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations